STAAR Surgical Cash Flow Statement
NASDAQ: STAAHealth CareOphthalmic GoodsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
STAAR Surgical free cash flow
In fiscal 2025, STAAR Surgical generated -$34.2 million of operating cash flow and spent $5.8 million on capital expenditures. That left free cash flow of -$40.0 million, a free-cash-flow margin of -16.7% of revenue. STAAR Surgical returned $6.5 million to shareholders through share repurchases.
Summary generated from market data by MetaCap's automated system. Methodology
STAAR Surgical cash flow statement (annual)
| Fiscal year (USD) | FY 20252026-01-02 | FY 20242024-12-27 | FY 20232023-12-29 | FY 20222022-12-30 | FY 20212021-12-31 | FY 20202021-01-01 | FY 20192020-01-03 | FY 20182018-12-28 | FY 20172017-12-29 | FY 20162016-12-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -80.45M | -20.21M | 21.35M | 39.66M | 27.51M | 5.91M | 14.05M | 4.97M | -2.14M | -12.13M |
| Net Income growth (YoY) | — | -194.66% | -46.18% | +44.18% | +365.26% | -57.91% | +182.77% | — | — | — |
| Depreciation & Amortization | 8.32M | 6.89M | 5.11M | 4.48M | 3.61M | 3.06M | 3.67M | 2.43M | 3.13M | 2.66M |
| Stock-Based Compensation | 30.59M | 27.21M | 23.52M | 20.37M | 14.61M | 12.15M | 10.55M | 6.76M | 3.16M | 8.56M |
| Change in Working Capital | 789.00K | 6.40M | -40.68M | -25.74M | -8.69M | -6.56M | -4.37M | -9.99M | -4.05M | 449.00K |
| Operating Cash Flow | -34.23M | 15.72M | 14.59M | 35.72M | 43.96M | 20.95M | 25.80M | 12.77M | 2.85M | 1.05M |
| Capital Expenditures | -5.82M | -23.39M | -18.19M | -18.11M | -13.64M | -8.40M | -10.10M | -2.25M | -1.05M | -3.21M |
| Investing Cash Flow | 46.34M | -59.22M | 74.35M | -156.38M | -13.64M | -8.40M | -10.18M | -2.25M | -1.05M | -3.21M |
| Share Repurchases | -6.46M | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | -4.55M | 5.72M | 7.42M | 8.30M | 17.79M | 19.57M | 149.00K | 74.64M | 2.44M | 2.95M |
| Net Change in Cash | 8.99M | -38.88M | 96.56M | -113.23M | 47.25M | 32.48M | 15.97M | 85.36M | 4.52M | 597.00K |
| Free Cash Flow | -40.05M | -7.67M | -3.59M | 17.61M | 30.32M | 12.55M | 15.70M | 10.52M | 1.81M | -2.16M |
This table shows 10 annual periods of STAAR Surgical's cash flow statement, from FY 2025 back to FY 2016, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow STAA's reporting calendar. What is a cash flow statement?